Pfizer facing three Celebrex antitrust cases


Pfizer is facing three class actions that allege the pharmaceutical company improperly obtained a patent covering its arthritis drug Celebrex (celecoxib) and used it to force generic drug makers into settlements that delay their entry into the market, Law360 has reported.

Pfizer, Celebrex, antitrust